Artificial intelligence in central-peripheral interaction organ crosstalk: the future of drug discovery and clinical trials
Open Access
- 10 April 2025
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 215, 107734
Abstract
No abstract availableKeywords
Funding Information
- Beijing Nova Program (20220484162)
- National Natural Science Foundation of China (U21A20414)
This publication has 128 references indexed in Scilit:
- Natural Language Processing of Clinical Documentation to Assess Functional Status in Patients With Heart FailureJAMA Network Open, 2024
- Ethical Considerations in the Design and Conduct of Clinical Trials of Artificial IntelligenceJAMA Network Open, 2024
- Sex-Dimorphic Kidney-Brain Connectivity Map of MiceNeuroscience Bulletin, 2024
- Manipulation of Glutamatergic Neuronal Activity in the Primary Motor Cortex Regulates Cardiac Function in Normal and Myocardial Infarction MiceAdvanced Science, 2024
- The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretationEPMA Journal, 2024
- MRI anatomy and injuries of the fingersPediatric Radiology, 2023
- A strategy for advancing for population-based scientific discovery using the metabolome: the establishment of the Metabolomics Society Metabolomic Epidemiology Task GroupMetabolomics, 2021
- Glycemic homeostasis and hepatic metabolism are modified in rats with global cerebral ischemiaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- Metformin improves depressive-like symptoms in mice via inhibition of peripheral and central NF-κB-NLRP3 inflammation activationExperimental Brain Research, 2020
- Applications of deep learning for the analysis of medical dataArchives of Pharmacal Research, 2019